Want to see SGRY full AI Analyst Report?
SGRY Stock Chart & Stats
$15.73
-$0.23(-1.46%)
At close: 4:00 PM EDT
$15.73
-$0.23(-1.46%)
Day’s Range― - ―
52-Week Range$11.41 - $24.10
Previous CloseN/A
Volume650.92K
Average Volume (3M)1.37M
Market Cap
$2.03B
Enterprise Value$7.50K
Total Cash (Recent Filing)$216.70M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta1.20
Next Earnings
Nov 10, 2026EPS Estimate
0.12Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.69
Shares Outstanding130,788,160
10 Day Avg. Volume1,496,441
30 Day Avg. Volume1,374,058
Financial Highlights & Ratios
PEG Ratio0.47
Price to Book (P/B)1.15
Price to Sales (P/S)0.59
P/FCF Ratio10.05
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$17.90Price Target Upside13.80% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering6
EPS Forecast (FY)0.43
Revenue Forecast (FY)$3.41B
Bulls Say, Bears Say
Bulls Say
Same-facility Revenue GrowthSustained same-facility revenue growth indicates durable demand and pricing power within the core ASC and short-stay surgical footprint. Over 2–6 months this supports higher utilization, better fixed-cost absorption, and a structural revenue base less reliant on one-off acquisitions.
Physician Recruiting & Acuity ExpansionOngoing physician recruitment and rising case acuity enlarge referral networks and increase revenue per case. These durable improvements boost utilization, deepen partner relationships, and create a multi-quarter tailwind to organic revenue and ancillary service capture.
Portfolio Optimization Reduces LeverageA sizable divestiture that cuts leverage and simplifies the business is a structural improvement. Lower net leverage reduces interest sensitivity, increases financial flexibility for capital deployment, and sharpens focus on the higher-margin ASC/short-stay surgical strategy.
Bears Say
Elevated Leverage & Rising Interest ExpenseHigh interest costs and elevated leverage materially weaken earnings resiliency. Over the medium term, interest expense will constrain net income and free cash flow, limit strategic flexibility, and raise refinancing and covenant risk if operating volatility persists.
Persistent Net LossesOngoing net losses despite improving operating margins indicate below-the-line costs (interest, taxes, other) still outstrip operational gains. This limits retained earnings and ROE, hampering capital accumulation and long-term shareholder value creation until profitability turns consistently positive.
Commercial Payer Mix DeclineA structural shift toward higher government payer mix reduces average reimbursement per case and pressurizes margins. Over several quarters this can lower revenue per procedure and limit margin expansion unless offset by pricing, acuity shifts, or cost reductions.
Surgery Partners News
SGRY FAQ
What was Surgery Partners Inc.’s price range in the past 12 months?
Surgery Partners Inc. lowest stock price was $11.41 and its highest was $24.10 in the past 12 months.
What is Surgery Partners Inc.’s market cap?
Surgery Partners Inc.’s market cap is $2.03B.
When is Surgery Partners Inc.’s upcoming earnings report date?
Surgery Partners Inc.’s upcoming earnings report date is Nov 10, 2026 which is in 91 days.
How were Surgery Partners Inc.’s earnings last quarter?
Surgery Partners Inc. released its earnings results on Aug 10, 2026. The company reported $0.1 earnings per share for the quarter, beating the consensus estimate of $0.058 by $0.042.
Is Surgery Partners Inc. overvalued?
According to Wall Street analysts Surgery Partners Inc.’s price is currently Undervalued.
Does Surgery Partners Inc. pay dividends?
Surgery Partners Inc. does not currently pay dividends.
What is Surgery Partners Inc.’s EPS estimate?
Surgery Partners Inc.’s EPS estimate is 0.12.
How many shares outstanding does Surgery Partners Inc. have?
Surgery Partners Inc. has 130,788,160 shares outstanding.
What happened to Surgery Partners Inc.’s price movement after its last earnings report?
Surgery Partners Inc. reported an EPS of $0.1 in its last earnings report, beating expectations of $0.058. Following the earnings report the stock price went up 2.704%.
Which hedge fund is a major shareholder of Surgery Partners Inc.?
Currently, no hedge funds are holding shares in SGRY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Surgery Partners Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$17.90 (13.80% Upside)
$17.90 (13.80% Upside)
Blogger Sentiment
Bullish
SGRY Sentiment 75%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 2.3M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 4.1%
Last 30 Days ▲ 6.2%
Last 30 Days ▲ 6.2%
News Sentiment
Very Bullish
Bullish news 80%
Bearish news 20%
Bearish news 20%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-28.64%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
1.17%
Trailing 12-Months
Company Description
Surgery Partners Inc.
Surgery Partners, Inc. operates a nationwide network of surgical facilities and associated medical services across the United States. Its business is categorized into two segments: Surgical Facility Services and Ancillary Services. These surgical venues include both ambulatory surgery centers and dedicated surgical hospitals, delivering non-urgent surgical procedures across various specialties such as gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The surgical hospitals additionally offer comprehensive ancillary services, including diagnostic imaging, pharmacy, laboratory, obstetrics, oncology, physical therapy, and wound care. The dedicated Ancillary Services segment further encompasses multi-specialty physician practices, urgent care facilities, and anesthesia services. By December 31, 2021, the company's portfolio consisted of 126 surgical facilities—specifically, 108 ambulatory surgical centers and 18 surgical hospitals—situated across 31 states. Founded in 2004, Surgery Partners, Inc. maintains its headquarters in Brentwood, Tennessee.
SGRY Company Deck
SGRY Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call emphasized healthy organic performance (revenue growth, strong same-facility metrics, physician recruiting, case acuity expansion, sequential expense improvements) and a strategic portfolio optimization (Idaho Falls sale) expected to simplify the business, improve cash conversion and reduce leverage. Headwinds include a modest decline in adjusted EBITDA and margins year-to-date, higher interest expense, a ~350 bps decline in commercial mix, elevated leverage metrics, and muted M&A activity in 2026. On balance, the positives (organic growth, operational improvements, substantial deleveraging transaction and reaffirmed guidance) outweigh the negatives.View all SGRY earnings summariesSGRY Stock 12 Month Forecast
Average Price Target
$17.90
▲(13.80% Upside)
Technical Analysis
HCA Healthcare
―
Encompass Health
―
National Healthcare
―
Tenet Healthcare
―
Universal Health
―
Ownership Overview
1.73% Insiders
24.87% Mutual Funds
0.82% Other Institutional Investors
61.51% Public Companies and
Individual Investors